A 70-year-old with HTN and T2D has eGFR 42 and ACR 320 mg/g despite ACE inhibitor. Which additional therapy slows CKD progression and reduces CV event...

Question

A 70-year-old with HTN and T2D has eGFR 42 and ACR 320 mg/g despite ACE inhibitor. Which additional therapy slows CKD progression and reduces CV events?

Accepted Answer

SGLT2 inhibitor

Answer

Finerenone only

Answer

DPP-4 inhibitor

Answer

Niacin

Answer

Loop diuretic chronically

us-abim MCQ (SBA): Diabetic Kidney Disease-Therapy

A 70-year-old with HTN and T2D has eGFR 42 and ACR 320 mg/g despite ACE inhibitor. Which additional therapy slows CKD progression and reduces CV events?